- Home
- OBT vs ELDN Comparison
OBT vs ELDN Comparison
Compare OBT & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBT
- ELDN
- Stock Information
- Founded
- OBT 1892
- ELDN 2004
- Country
- OBT United States
- ELDN United States
- Employees
- OBT N/A
- ELDN N/A
- Industry
- OBT Major Banks
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- OBT Finance
- ELDN Health Care
- Exchange
- OBT Nasdaq
- ELDN Nasdaq
- Market Cap
- OBT 315.3M
- ELDN 288.5M
- IPO Year
- OBT N/A
- ELDN N/A
- Fundamental
- Price
- OBT $26.07
- ELDN $4.78
- Analyst Decision
- OBT Buy
- ELDN Strong Buy
- Analyst Count
- OBT 1
- ELDN 1
- Target Price
- OBT $35.50
- ELDN $16.00
- AVG Volume (30 Days)
- OBT 29.5K
- ELDN 331.1K
- Earning Date
- OBT 02-11-2025
- ELDN 03-27-2025
- Dividend Yield
- OBT 2.30%
- ELDN N/A
- EPS Growth
- OBT N/A
- ELDN N/A
- EPS
- OBT 2.56
- ELDN N/A
- Revenue
- OBT $98,024,000.00
- ELDN N/A
- Revenue This Year
- OBT N/A
- ELDN N/A
- Revenue Next Year
- OBT $4.83
- ELDN N/A
- P/E Ratio
- OBT $10.18
- ELDN N/A
- Revenue Growth
- OBT 4.93
- ELDN N/A
- 52 Week Low
- OBT $20.50
- ELDN $1.52
- 52 Week High
- OBT $33.06
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- OBT 39.58
- ELDN 62.27
- Support Level
- OBT $25.92
- ELDN $4.04
- Resistance Level
- OBT $26.79
- ELDN $4.85
- Average True Range (ATR)
- OBT 0.97
- ELDN 0.26
- MACD
- OBT 0.09
- ELDN 0.08
- Stochastic Oscillator
- OBT 33.76
- ELDN 93.22
About OBT Orange County Bancorp Inc.
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.